Sutro Biopharma, Inc. STRO
$20.48
-3.89%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-12 | View → |
| 8-K | 8-K | 2026-08-12 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 4 | Insider transaction | 2026-06-09 | View → |
| 8-K | 8-K | 2026-06-08 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 10-Q | 10-Q | 2026-05-14 | View → |
| 8-K | 8-K | 2026-05-14 | View → |
| DEF 14A | DEF 14A | 2026-04-22 | View → |
| S-3 | S-3 | 2026-03-23 | View → |
| 10-K | 10-K | 2026-03-23 | View → |
| 8-K | 8-K | 2026-03-23 | View → |
| 4 | Insider transaction | 2026-03-06 | View → |
| 4 | Insider transaction | 2026-03-06 | View → |
| 4 | Insider transaction | 2026-03-03 | View → |
| 4 | Insider transaction | 2026-03-03 | View → |
| 4 | Insider transaction | 2026-03-03 | View → |
| 4 | Insider transaction | 2026-03-03 | View → |
| 8-K | 8-K | 2026-02-10 | View → |
| 424B5 | 424B5 | 2026-02-10 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 4 | Insider transaction | 2025-12-29 | View → |
| 8-K | 8-K | 2025-12-17 | View → |
| 4 | Insider transaction | 2025-12-16 | View → |
| 8-K | 8-K | 2025-12-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $20.48
- Market Cap
- $339.58 million
- 52-Week Range
- $7.15 – $43.85
- Average Volume
- 319K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.